Actively Recruiting
Individualizing Corticosteroid Use in Pneumonia
Led by Mayo Clinic · Updated on 2026-04-23
24
Participants Needed
1
Research Sites
107 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, researchers propose a unique (individualized) approach to steroid treatment seeking to give the right dose of steroid to the right patient and at the right time. This study seeks to compare usual care to an individualized steroid dosing strategy by testing a marker of inflammation in the blood called C- reactive protein (CRP). The overall goal is to reduce an individual's exposure to steroids and the risk of potential side effects thereby increasing the potential benefit of using steroids to control inflammation in pneumonia.
CONDITIONS
Official Title
Individualizing Corticosteroid Use in Pneumonia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospitalized adult (≥ 18 years) patients
- Community acquired pneumonia
You will not qualify if you...
- Contraindications or unwillingness to use corticosteroids by patient or provider
- History of adrenal insufficiency, septic shock, or another absolute indication for steroid use
- Suspected pulmonary vasculitis or other autoimmune pulmonary disorder
- Positive pregnancy test
- Comfort care
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
Y
Yewande Odeyemi, M.B.B.S.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here